Home/Filings/4/0000899140-24-001385
4//SEC Filing

SUVRETTA CAPITAL MANAGEMENT, LLC 4

Accession 0000899140-24-001385

CIK 0001808898other

Filed

Dec 25, 7:00 PM ET

Accepted

Dec 26, 4:28 PM ET

Size

34.1 KB

Accession

0000899140-24-001385

Insider Transaction Report

Form 4
Period: 2024-12-23
Averill Master Fund, Ltd.
Director10% Owner
Transactions
  • Purchase

    Common stock, par value $0.0001 per share

    2024-12-24$11.25/sh+17,730$199,4637,999,455 total(indirect: See footnotes)
  • Purchase

    Common stock, par value $0.0001 per share

    2024-12-24$11.25/sh+2,288$25,740960,554 total(indirect: See footnotes)
  • Purchase

    Common stock, par value $0.0001 per share

    2024-12-23$10.98/sh+24,360$267,4737,981,725 total(indirect: See footnotes)
  • Purchase

    Common stock, par value $0.0001 per share

    2024-12-23$10.98/sh+3,142$34,499958,266 total(indirect: See footnotes)
Transactions
  • Purchase

    Common stock, par value $0.0001 per share

    2024-12-24$11.25/sh+17,730$199,4637,999,455 total(indirect: See footnotes)
  • Purchase

    Common stock, par value $0.0001 per share

    2024-12-24$11.25/sh+2,288$25,740960,554 total(indirect: See footnotes)
  • Purchase

    Common stock, par value $0.0001 per share

    2024-12-23$10.98/sh+3,142$34,499958,266 total(indirect: See footnotes)
  • Purchase

    Common stock, par value $0.0001 per share

    2024-12-23$10.98/sh+24,360$267,4737,981,725 total(indirect: See footnotes)
Transactions
  • Purchase

    Common stock, par value $0.0001 per share

    2024-12-23$10.98/sh+3,142$34,499958,266 total(indirect: See footnotes)
  • Purchase

    Common stock, par value $0.0001 per share

    2024-12-23$10.98/sh+24,360$267,4737,981,725 total(indirect: See footnotes)
  • Purchase

    Common stock, par value $0.0001 per share

    2024-12-24$11.25/sh+17,730$199,4637,999,455 total(indirect: See footnotes)
  • Purchase

    Common stock, par value $0.0001 per share

    2024-12-24$11.25/sh+2,288$25,740960,554 total(indirect: See footnotes)
Cowen Aaron
10% Owner
Transactions
  • Purchase

    Common stock, par value $0.0001 per share

    2024-12-23$10.98/sh+24,360$267,4737,981,725 total(indirect: See footnotes)
  • Purchase

    Common stock, par value $0.0001 per share

    2024-12-23$10.98/sh+3,142$34,499958,266 total(indirect: See footnotes)
  • Purchase

    Common stock, par value $0.0001 per share

    2024-12-24$11.25/sh+17,730$199,4637,999,455 total(indirect: See footnotes)
  • Purchase

    Common stock, par value $0.0001 per share

    2024-12-24$11.25/sh+2,288$25,740960,554 total(indirect: See footnotes)
Footnotes (5)
  • [F1]Notes are included on Exhibit 99.1.
  • [F2]Notes are included on Exhibit 99.1.
  • [F3]Notes are included on Exhibit 99.1.
  • [F4]Notes are included on Exhibit 99.1.
  • [F5]Notes are included on Exhibit 99.1.

Issuer

Benitec Biopharma Inc.

CIK 0001808898

Entity typeother
IncorporatedDE

Related Parties

1
  • filerCIK 0001569064

Filing Metadata

Form type
4
Filed
Dec 25, 7:00 PM ET
Accepted
Dec 26, 4:28 PM ET
Size
34.1 KB